The sucessful tumor cell integration of these multi-functionalized nanoparticles proved to drastically suppress tumorigenesis by targeting mTOR, PAK4, RHOC, and the epithelial–mesenchymal transition (EMT) in hepatocellular carcinoma (HCC) PDX models. This evidence concerns the gene PAK4 and hepatocellular carcinoma.